Paroxetine: current status in psychiatry
@article{Pae2007ParoxetineCS, title={Paroxetine: current status in psychiatry}, author={C. Pae and A. Patkar}, journal={Expert Review of Neurotherapeutics}, year={2007}, volume={7}, pages={107 - 120} }
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) with antidepressant and anxiolytic properties. It is commercially available in both an immediate-release (paroxetine) and a controlled-release formulation (paroxetine CR). The latter product was developed to improve gastrointestinal tolerability. Paroxetine is the most potent inhibitor of the reuptake of serotonin among the available SSRIs. It has approved indications for the treatment of major depression, obsessive–compulsive… CONTINUE READING
Topics from this paper
39 Citations
Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder
- Medicine
- Expert review of neurotherapeutics
- 2007
- 9
A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?
- Psychology, Medicine
- International clinical psychopharmacology
- 2014
- 113
Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
- Medicine, Psychology
- Journal of psychopharmacology
- 2009
- 47
- PDF
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
- Medicine
- Pharmacogenomics
- 2010
- 28
Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
- Psychology, Medicine
- The international journal of neuropsychopharmacology
- 2009
- 74
- PDF
Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.
- Psychology, Medicine
- The American journal of psychiatry
- 2012
- 86
- PDF
Effect of comedication of bupropion and other antidepressants on body mass index
- Medicine
- Therapeutic advances in psychopharmacology
- 2015
- 5
Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting
- Medicine
- International Journal of Impotence Research
- 2014
- 21
Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms.
- Psychology, Medicine
- Comprehensive psychiatry
- 2009
- 10
References
SHOWING 1-10 OF 109 REFERENCES
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
- Medicine
- Drugs
- 1998
- 133
Efficacy of controlled-release paroxetine in the treatment of late-life depression.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2003
- 107
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.
- Medicine, Psychology
- The Journal of clinical psychiatry
- 2003
- 113
Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2002
- 100
Selective serotonin reuptake inhibitors in the treatment of affective disorders—III. Tolerability, safety and pharmacoeconomics
- Medicine
- Journal of psychopharmacology
- 1998
- 161
Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression.
- Psychology, Medicine
- The American journal of psychiatry
- 1998
- 167
Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.
- Medicine
- Expert opinion on investigational drugs
- 1999
- 22
Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2004
- 57